Both in Pharmaceuticals
LB Pharmaceuticals vs Omeros
Over the past year LBRX returned +137.2% and OMER returned +126.6%; their daily moves had a correlation of 0.15.
LBRX +137.2% OMER +126.6%Growth of $1, one year, split-adjusted
| Metric | LBRX | OMER |
|---|---|---|
| Price | $39.61 | $17.47 |
| Market cap | $1.28B | $1.26B |
| Today | −0.09% | −0.11% |
| 1 month | +6.2% | −9.2% |
| 6 months | +29.5% | +20.0% |
| Year to date | +77.9% | +1.7% |
| 1 year | +137.2% | +126.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 10.1× |
| Price / sales | — | 32.9× |
| Net cash | $327.8M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 75.7% |
| Short % of float | 23.0% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).